Latest Global Expansion News

RocketBoots reported a 9.7% revenue rise to A$724,815 but deepened its net loss to A$6.6 million, driven by heavy investment ahead of a major contract rollout and international growth.

Lovisa Holdings reported a robust FY26 with revenue up 17.6% to A$938.8 million, expanded its global store network to 1,136 locations, and declared a 33 cent final dividend, reflecting strong momentum in key markets.

Advanced Braking Technology Ltd (ASX: ABV) posted a 22.7% revenue increase to $23.48 million and a 16.6% rise in net profit after tax to $2.075 million for FY26, driven by international expansion and advances in autonomous braking technology.

Mader Group Limited has surpassed $1 billion in revenue for the first time, reporting a 15% increase in both revenue and net profit after tax for the financial year ended 30 June 2026. The company continues to expand its global footprint with strong growth in Australia and North America.

Servcorp Limited delivered a record FY26 with a 24% rise in underlying NPBIT to $87 million, boosted dividends by 14%, and outlined a cautious yet optimistic FY27 growth strategy.

Lycopodium Limited reported a solid FY26 with $377.5 million revenue, a slight profit dip, and a 69% dividend hike, while setting sights on accelerated growth in the Americas.

Scott Technology has locked in NZ$20 million worth of new Materials Handling & Logistics contracts across North America and Europe, reinforcing its Destination 2030 growth strategy and building on strong FY26 momentum.

The Calmer Co. has pushed back the closing date of its $3.5 million renounceable entitlement offer to give shareholders more time to participate, including those overseas.

Kelly Partners Group Holdings boosted FY26 revenue by 18.2% to $159.2 million, underpinned by six acquisitions including a key US CPA firm. Underlying NPATA rose 18.9% to $10.8 million, while the group deepened its global footprint across five countries.

Chrysos Corporation posted a 33% revenue increase and 68% EBITDA growth in FY26, driven by expanding its PhotonAssay™ technology fleet to 46 units worldwide and signing 24 new lease agreements.

ReNerve Limited has gained marketing approval for its flagship NervAlign Nerve Cuff in India, marking a critical milestone in its global expansion and enabling commercial rollout in one of the world's largest nerve repair markets.

Rua Bioscience has approved a $600,000 convertible note facility aimed at boosting inventory purchases to accelerate its UK market expansion following a major distribution deal.